Participation of prostaglandin E2 receptor in nasal congestion of brown Norway rats

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 1, 2010, Pages 64-66

  Kurata, Yasunori ^a   Yamamoto, Atsuki ^a   Izawa, Kana ^a   Akagi, Masaaki ^b   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Brown Norway rat; Enhanced pause; Nasal congestion; Prostaglandin E2; Toluene 2,4 diisocyanate

Indexed keywords

17 PHENYL TRINOR PROSTAGLANDIN E2; BUTAPROST; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1 ALCOHOL; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; SULPROSTONE; TOLUENE DIISOCYANATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN NORWAY RAT; CONTROLLED STUDY; IMMUNE RESPONSE; MALE; NONHUMAN; NOSE CONGESTION; PROVOCATION TEST; RAT; SENSITIZATION; SNEEZING;

ALPROSTADIL; ANIMALS; ANTI-ALLERGIC AGENTS; DINOPROSTONE; MODELS, ANIMAL; NASAL MUCOSA; RATS; RATS, INBRED BN; RECEPTORS, PROSTAGLANDIN; RHINITIS, ALLERGIC, PERENNIAL; SNEEZING; TOLUENE 2,4-DIISOCYANATE;

EID: 75149182807     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.64     Document Type: Article

References (19)

1. White M. V., Kaliner M. A., J. Allergy Clin. Immunol., 90, 699-704 (1992).
2. Naclerio R. M., Meier H. L., Kagey-Sobotka A., Adkinson N. F. Jr., Meyers D. A., Norman P. S., Lichtenstein L. M., Am. Rev. Respir. Dis., 128, 597-602 (1983).
3. Skoner D. P., J. Allergy Clin. Immunol., 108 (Suppl. 1), S2-S8 (2001).
4. Krause H. F., Otolaryngol. Head Neck Surg., 111, 364-372 (1994).
5. Du Buske L. M., J. Allergy Clin. Immunol., 98, S307-S318 (1996).
6. Meltzer E. O., Malmstrom K., Lu S., Prenner B. M., Wei L. X., Weinstein S. F., Wolfe J. D., Reiss T. F., J. Allergy Clin. Immunol., 105, 917-922 (2000).
7. Fujita M., Yonetomi Y., Shimouchi K., Takeda H., Aze Y., Kawabata K., Ohno H., Eur. J. Pharmacol., 369, 349-356 (1999).
8. Kishi Y., Nakano Y., Jiang S., Yatsuzuka R., Kamei C., Int. Immunopharmacol., 7, 1483-1487 (2007).
9. Tsumuro T., Alejandra Hossen M., Kishi Y., Fujii Y., Kamei C., Int. Immunopharmacol., 6, 759-763 (2006).
10. Kunikata T., Yamane H., Segi E., Matsuoka T., Sugimoto Y., Tanaka S., Tanaka H., Nagai H., Ichikawa A., Narumiya S., Nat. Immunol., 6, 524-531 (2005).
11. Gomi K., Zhu F. G., Marshall J. S., J. Immunol., 165, 6545-6552 (2000).
12. Chung K. F., Sci. STKE, 303, pe47 (2005).
13. Matsuoka T., Narumiya S., Scientific World Journal, 7, 1329-1347 (2007).
14. Nagai H., Allergol. Int., 57, 187-196 (2008).
15. Ogidigben M. J., Chu T. C., Potter D. E., Pharmacology, 65, 155-161 (2002).
16. Tanaka Y., Mizutani N., Fujii M., Nabe T., Kohno S., Prostaglandins Other Lipid Mediat., 80, 144-154 (2006).
17. Tang L., Loutzenhiser K., Loutzenhiser R., Circ. Res., 86, 663-670 (2000).
18. Kabashima K., Sakata D., Nagamachi M., Miyachi Y., Inaba K., Narumiya S., Nat. Med., 6, 744-749 (2003).
19. Okumura T., Murata Y., Taniguchi K., Murase A., Nii A., J. Pharm. Pharmacol., 60,723-770 (2008).